A Phase II Efficacy Study of Intracerebral CTX0E03 DP in Patients With Stable Paresis of the Arm Following an Ischaemic Stroke.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2017
At a glance
- Drugs ReN 001 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms PISCES II
- Sponsors ReNeuron
- 29 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Sep 2017.
- 13 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 21 Jun 2016 Planned number of patients changed from 41 to 21.